Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas

Journal of Neuro-Oncology

Volumn 100, Issue 2, 2010, Pages 217-223

  Tseng, Kuan Yin ^a   Chung, Min Huey ^b   Sytwu, Huey Kang ^c   Lee, Horng Mo ^d,g   Chen, Kuan Yu ^a   Chang, Chen ^e   Lin, Chih Kung ^a   Yen, Che Hung ^a   Chen, Jia Hong ^a   Lin, Gu Jiun ^c   Ma, Hsin I ^a,c   Yeh, Yi Shian ^f   Ju, Da Tong ^a   Liu, Ming Ying ^a   Hueng, Dueng Yuan ^a,c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Allred score; Immunohistochemical staining; Meningioma; Osteopontin; Recurrence

Indexed keywords

OSTEOPONTIN;

ADULT; ALFRED SCORE; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCORING SYSTEM; STAINING;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEOPONTIN; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 79952194639     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0164-2     Document Type: Article

References (23)

1. Maiuri F, De Caro Mdel B, Esposito F, Cappabianca P, Strazzullo V, Pettinato G, de Divitiis E (2007) Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol 82:63-68
2. Vankalakunti M, Vasishta RK, Das Radotra B, Khosla VK (2007) MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. Neuropathology 27:407-412 (Pubitemid 47459713)
3. Chakraborty G, Jain S, Behera R, Ahmed M, Sharma P, Kumar V, Kundu GC (2006) The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr Mol Med 6:819-830 (Pubitemid 44883934)
4. Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30-31:92-102 (Pubitemid 29028730)
5. Weber GF (2001) The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552:61-85
6. Furger KA, Menon RK, Tuck AB, Bramwell VH, Chambers AF (2001) The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med 1:621-632 (Pubitemid 33772040)
7. Tuck AB, Chambers AF (2001) The role of osteopontin in breast cancer: clinical and experimental studies. J Mammary Gland Biol Neoplasia 6:419-429
8. Tuck AB, Elliott BE, Hota C, Tremblay E, Chambers AF (2000) Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J Cell Biochem 78:465-475 (Pubitemid 30491074)
9. Toy H, Yavas O, Eren O, Genc M, Yavas C (2009) Correlation between osteopontin protein expression and histological grade of astrocytomas. Pathol Oncol Res 15:203-207
10. Tunio GM, Hirota S, Nomura S, Kitamura Y (1998) Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer. Arch Pathol Lab Med 122:1087-1090 (Pubitemid 29009401)
11. Ho DM, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538-1547 (Pubitemid 34212649)
12. Takahashi JA, Ueba T, Hashimoto N, Nakashima Y, Katsuki N (2004) The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas. Surg Neurol 61: 149-155; discussion 155-146
13. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, Yeatman TJ (2004) Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10:184-190
14. Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 98:119-127
15. Jan HJ, Lee CC, Shih YL, Hueng DY, Ma HI, Lai JH, Wei HW, Lee HM (2010) Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro Oncol 12:58-70
16. Bellahcene A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8:212-226 (Pubitemid 351301854)
17. Shijubo N, Uede T, Kon S, Nagata M, Abe S (2000) Vascular endothelial growth factor and osteopontin in tumor biology. Crit Rev Oncog 11:135-146
18. Mantle RE, Lach B, Delgado MR, Baeesa S, Belanger G (1999) Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 91:375-383 (Pubitemid 29404427)
19. Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, Jung HW (2002) Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol 60:235-245 (Pubitemid 35439178)
20. Hsu DW, Efird JT, Hedley-Whyte ET (1998) MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 24:441-452 (Pubitemid 29002275)
21. Karja V, Sandell PJ, Kauppinen T, Alafuzoff I (2010) Does protein expression predict recurrence of benign World Health Organization grade I meningioma? Hum Pathol 41:199-207
22. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A (2007) Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27:114-120 (Pubitemid 46558206)
23. Keizman D, Issakov J, Meller I, Maimon N, Ish-Shalom M, Sher O, Merimsky O (2009) Expression and significance of EGFR in malignant peripheral nerve sheath tumor. J Neurooncol 94:383-388